drugset / Trial / NCT05580107
MDPK67b in Patients With Prostate Cancer
NaSequentialOpen-labelTreatment
Summary
Administration of MDPK67b to assess its Tolerability and Safety profile in prostate cancer patients, and to assess histo-pathological and molecular changes in prostate tumor tissue samples.
Timeline
- Start
- 2021-08-09
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MDPK67b | Unknown | 24 mg | — |
| Subject | MDPK67b | Unknown | 48 mg | — |